Verve Therapeutics, Inc. Common Stock

  • VERV

  • $11.20

  • +0.90%

  • $11.10

  • $11.25

  • $11.10

Prices as of 2025-07-24 16:20:04 ET

Ticker Appearances

Signal From Noise
Sat, April 5, 2025 | 10:30AM ET
Group135
Fundstrat Direct Team

CRISPR ― Improving Our Original Recipes

In 2020, Drs. Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize in Chemistry for developing the gene-editing tool known as CRISPR. In the words...

Events

Tickers

Trending tickers in our research